Technetium lymphoscintigraphy
Showing 1 - 25 of 139
Malignant Melanoma, Merkel Cell Carcinoma Trial in Bern (Visionsense™ VS3 - Stereoscopic High Definition Visualisation System
Completed
- Malignant Melanoma
- Merkel Cell Carcinoma
- Visionsense™ VS3 - Stereoscopic High Definition Visualisation System (VS3-3DHD)
-
Bern, Kanton Bern, SwitzerlandInselspital, University Hospital Bern, University of Bern
Dec 7, 2022
Pediatric Patients With Solid Tumors Trial in New York, Memphis, Houston (Sentinel Lymph Node Biopsy, indocyanine green (ICG))
Active, not recruiting
- Pediatric Patients With Solid Tumors
- Sentinel Lymph Node Biopsy
- indocyanine green (ICG)
-
New York, New York
- +2 more
Nov 29, 2021
Melanoma Trial in Sittard (Diagnostic Test: Sentinel node mapping using MRI)
Not yet recruiting
- Melanoma
- Diagnostic Test: Sentinel node mapping using MRI
-
Sittard, Limburg, NetherlandsZuyderland Medical Center
Jul 11, 2022
Invasive Breast Cancer, Ipsilateral Recurrence, Sentinel Lymph Node Biopsy Trial in France (Sentinel LN in breast cancer
Terminated
- Invasive Breast Cancer
- +2 more
- Sentinel LN in breast cancer recurrence
-
Bordeaux, France
- +8 more
Apr 19, 2022
Breast Carcinoma, Head Neck Cancer, Melanoma (Skin) Trial in Vandoeuvre-les-Nancy (Indocyanine green, Technetium99, Optonuclear
Recruiting
- Breast Carcinoma
- +9 more
- Indocyanine green
- +3 more
-
Vandoeuvre-les-Nancy, FranceInstitut de Cancérologie de Lorraine
Mar 29, 2022
Multispectral Fluorescence asTool to Separate Healthy and
Recruiting
- Prostate Cancer
- multispectral imaging
-
Amsterdam, NetherlandsNetherlands Cancer Institute
Aug 18, 2022
Cancer T1-N0 or T2-N0 of the Oral Cavity Trial in Montpellier (outpatient surgery for T1-N0 or T2-N0 cancers of the oral cavity
Recruiting
- Cancer T1-N0 or T2-N0 of the Oral Cavity
- outpatient surgery for T1-N0 or T2-N0 cancers of the oral cavity or oropharynx with lymph node search
-
Montpellier, Hérault, FranceGui de Chauliac Hospital, ENT Department 80 rue Augustin Fliche
Mar 30, 2022
Sentinel Lymph Node, Melanoma (Skin), Breast Cancer Trial in Atlanta, Poughkeepsie, Hershey (IC-Green KIT)
Completed
- Sentinel Lymph Node
- +2 more
- IC-Green KIT
-
Atlanta, Georgia
- +2 more
Dec 19, 2022
Melanoma, Stage I, Melanoma, Stage II, Melanoma Stage III Trial (MSOT)
Not yet recruiting
- Melanoma, Stage I
- +2 more
- MSOT
- (no location specified)
Jul 15, 2022
Vulvar Cancer Trial in United States (ICG guided sentinel lymph node biopsy)
Recruiting
- Vulvar Cancer
- ICG guided sentinel lymph node biopsy
-
Basking Ridge, New Jersey
- +6 more
Nov 7, 2023
Secondary Lymphedema Due to Human Adjuvant Disease
Completed
- Lymphedema, Secondary
- +2 more
- Lower extremity Lymphoscintigraphy
-
Mexico City, Cdmx, MexicoHospital Angeles Pedregal
Oct 8, 2020
Squamous Cell Carcinoma, Nonmelanoma Skin Cancer, Cutaneous Squamous Cell Carcinoma Trial in Indianapolis (sentinel lymph node
Recruiting
- Squamous Cell Carcinoma
- +2 more
- sentinel lymph node biopsy (SLNB)
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Nov 15, 2022
Head and Neck Squamous Cell Carcinoma Trial in Palo Alto (Panitumumab-IRDye800, Lymphoseek)
Suspended
- Head and Neck Squamous Cell Carcinoma
-
Palo Alto, CaliforniaStanford University, School of Medicine
Aug 16, 2021
Oropharynx Cancer Trial in Philadelphia (Radiation therapy (5 days for 7 weeks), Radiation therapy (5 days for 6 weeks),
Recruiting
- Oropharynx Cancer
- Radiation therapy (5 days for 7 weeks)
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 5, 2023
Melanoma, Sentinel Lymph Node Trial in Gothenburg (SLN Biopsy with Magtrace®/Sentimag®)
Completed
- Melanoma
- Sentinel Lymph Node
- SLN Biopsy with Magtrace®/Sentimag®
-
Gothenburg, SwedenSahlgrenska University Hospital
Oct 19, 2020
Breast Cancer Trial in Houston (num Vapocoolant)
Recruiting
- Breast Cancer
- num Vapocoolant
-
Houston, TexasMD Anderson Cancer Center
Mar 1, 2023
Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,
Recruiting
- Systemic Amyloidosis
- 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
- 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 10, 2023
Breast Cancer, Lymphedema Trial in Rochester (other, procedure, radiation)
Completed
- Breast Cancer
- Lymphedema
- screening questionnaire administration
- +5 more
-
Rochester, MinnesotaMayo Clinic
Oct 4, 2018
Breast Cancer Trial in Strasbourg (drug, procedure, radiation)
Terminated
- Breast Cancer
- patent blue V dye
- +4 more
-
Strasbourg, FranceCentre Paul Strauss
Feb 19, 2021
Carcinoma, Carcinoma, Hepatocellular, Liver Tumor Trial in Spokane (99mTc-Macro Albumin Aggregate)
Recruiting
- Carcinoma
- +2 more
- 99mTc-Macro Albumin Aggregate
-
Spokane, WashingtonInland Imaging
May 4, 2023
Vulvar Cancer, Sentinel Lymph Node Trial in Copenhagen
Recruiting
- Vulvar Cancer
- Sentinel Lymph Node
-
Copenhagen, DenmarkCopenhagen University Hospital
Sep 1, 2023
Malignant Melanoma Trial in Kansas City (Wide Local Excision)
Completed
- Malignant Melanoma
- Wide Local Excision
-
Kansas City, KansasUniversity of Kansas Medical Center
Apr 29, 2021
Mapping and Quantifying Lymphatic Drainage of Arm's Alternate
Recruiting
- Lymphatic System
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 3, 2022
Prostate Cancer Trial in Tomsk (Whole body study and SPECT with [99mTc]Tc-BQ0413)
Enrolling by invitation
- Prostate Cancer
- Whole body study and SPECT with [99mTc]Tc-BQ0413
-
Tomsk, Russian FederationTomskNRMC
Oct 26, 2023
Early Diagnosis of Breast Cancer-related Lymphedema
Recruiting
- Lymphedema
- lymphoscintigraphy
- +3 more
-
Kaohsiung, TaiwanKaohsiung Veterans General Hospital
Sep 18, 2023